Clinical Trials

NCT05866471 | RECRUITING | PHASE1

108 participants

The ENHANCE Study: taVNS and Psilocybin

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2025-01-27

Completion:

2027-11-30

Conditions

• Healthy
• Psychedelic Experiences
• Vagus Nerve Stimulation

Interventions

• DRUG
• DEVICE
• BEHAVIORAL
• OTHER

No Results Yet

NCT05856994 | TERMINATED | PHASE1

1 participants

Clinical Assessment of Protopic® Ointment in Deep Partial-Thickness Burns

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2024-09-19

Completion:

2026-01-12

Conditions

• Burn Injury

Interventions

• DRUG

No Results Yet

NCT05851391 | RECRUITING | PHASE2

30 participants

buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2023-08-07

Completion:

2027-11-30

Conditions

• Hypoxia-Ischemia, Brain
• Heart Arrest
• Status Epilepticus
• Refractory Status Epilepticus
• Seizures
• Anoxic-Ischemic Encephalopathy
• Anoxia-Ischemia, Cerebral

Interventions

• DRUG

No Results Yet

NCT05844293 | ACTIVE_NOT_RECRUITING | PHASE1

40 participants

Single Ascending Dose of FXI-GalNAc-siRNA in Healthy Subjects

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2023-05-16

Completion:

2027-05-31

Conditions

• FXI

Interventions

• DRUG
• OTHER

No Results Yet

NCT05827549 | RECRUITING | PHASE2

90 participants

Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2024-04-04

Completion:

2032-12-31

Conditions

• Acute Lymphoid Leukemia

Interventions

• DRUG
• PROCEDURE

No Results Yet

NCT05819866 | ACTIVE_NOT_RECRUITING | PHASE3

40 participants

A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2023-07-12

Completion:

2027-05-31

Conditions

• Cerebral Adrenoleukodystrophy (cALD)

Interventions

• DRUG

No Results Yet

NCT05816265 | TERMINATED | PHASE4

6 participants

Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2024-01-24

Completion:

2025-11-18

Conditions

• Heart Failure
• Iron-deficiency

Interventions

• DRUG

No Results Yet

NCT05796388 | RECRUITING | NA

65 participants

A Study of Virtual Reality and Linaclotide for IBS-C

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2024-05-31

Completion:

2026-10-31

Conditions

• Irritable Bowel Syndrome With Constipation

Interventions

• DEVICE

No Results Yet

NCT05781893 | COMPLETED

196 participants

Basel Long COVID-19 Cohort Study and Digital Long COVID Substudy

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-29

Start Date:

2023-04-20

Completion:

2026-05-06

Conditions

• Post COVID-19 Condition (PCC)

Interventions

• OTHER

No Results Yet

NCT05773040 | RECRUITING | PHASE1

33 participants

A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2023-04-14

Completion:

2028-12-31

Conditions

• Lymphomas
• B-cell Lymphomas

Interventions

• DRUG
• PROCEDURE

No Results Yet

NCT05771480 | ACTIVE_NOT_RECRUITING | PHASE3

142 participants

Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs)

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2023-08-16

Completion:

2025-10-02

Conditions

• Biliary Tract Cancer

Interventions

• DRUG
• BIOLOGICAL

No Results Yet

NCT05756569 | RECRUITING | PHASE2

25 participants

Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2023-09-26

Completion:

2026-12-16

Conditions

• Bladder Squamous Cell Carcinoma
• Locally Advanced Bladder Carcinoma
• Malignant Renal Pelvis Neoplasm
• Malignant Ureter Neoplasm
• Malignant Urethral Neoplasm
• Metastatic Bladder Carcinoma
• Stage III Bladder Cancer AJCC v8
• Stage IV Bladder Cancer AJCC v8
• Unresectable Bladder Carcinoma
• Urachal Adenocarcinoma
• Bladder Adenocarcinoma

Interventions

• PROCEDURE
• DRUG
• BIOLOGICAL
• OTHER

No Results Yet

NCT05739383 | ACTIVE_NOT_RECRUITING | PHASE3

14012 participants

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2023-03-09

Completion:

2029-04-16

Conditions

• Primary Prevention of Atherosclerotic Cardiovascular Disease

Interventions

• DRUG

No Results Yet

NCT05727761 | RECRUITING | PHASE2

36 participants

Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2025-01-01

Completion:

2027-07-30

Conditions

• Oral Leukoplakia

Interventions

• DRUG

No Results Yet

NCT05714150 | COMPLETED | NA

21 participants

Balance After Traumatic Brain Injury

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2024-03-21

Completion:

2026-06-30

Conditions

• Traumatic Brain Injury

Interventions

• BEHAVIORAL

No Results Yet

NCT05692804 | COMPLETED

59 participants

Evaluation of Neuronal Damage in Patients Undergoing Robot-assisted Laparoscopic Radical Prostatectomy With Biomarkers

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-29

Start Date:

2022-03-08

Completion:

2024-06-28

Conditions

• Brain Damage
• Postoperative
• Surgery-Complications

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT05680818 | ACTIVE_NOT_RECRUITING | PHASE3

67 participants

Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2023-01-06

Completion:

2025-08-22

Conditions

• Autosomal Dominant Hypocalcemia (ADH)

Interventions

• DRUG
• DIETARY_SUPPLEMENT

No Results Yet

NCT05678673 | ACTIVE_NOT_RECRUITING | PHASE3

317 participants

Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2023-01-01

Completion:

2026-12-15

Conditions

• Non-Clear Cell Renal Cell Carcinoma

Interventions

• DRUG

No Results Yet

NCT05671419 | RECRUITING | NA

40 participants

Mindful Self-Compassion for Anxiety Disorders and Depression

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2022-01-16

Completion:

2025-10-02

Conditions

• Anxiety Disorders
• Generalized Anxiety Disorder
• Social Anxiety Disorder
• Social Phobia
• Panic Disorder
• Agoraphobia
• Major Depressive Disorder

Interventions

• BEHAVIORAL

No Results Yet

NCT05667766 | ACTIVE_NOT_RECRUITING | NA

441 participants

Minimising Adverse Drug Reactions and Verifying Economic Legitimacy in Children (MARVEL-PIC)

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2023-03-22

Completion:

2026-06-30

Conditions

• Neoplasms
• Bone Marrow Transplantation

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT05665361 | RECRUITING | PHASE1/PHASE2

100 participants

Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2024-04-24

Completion:

2027-06-01

Conditions

• Advanced Clear Cell Renal Carcinoma (Ccrcc)
• Papillary Renal Cell Carcinoma (Prcc)

Interventions

• DRUG

No Results Yet

NCT05655182 | RECRUITING | PHASE1/PHASE2

137 participants

A Study of BLB-201 RSV Vaccine in Infants and Children

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2023-03-09

Completion:

2028-12-30

Conditions

• Respiratory Syncytial Virus Infections

Interventions

• BIOLOGICAL
• DRUG

No Results Yet

NCT05645107 | RECRUITING | PHASE3

386 participants

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2022-12-26

Completion:

2029-08-31

Conditions

• Hypogammaglobulinemia
• Bacterial Infections
• B-cell Chronic Lymphocytic Leukemia
• Multiple Myleoma
• Non-Hodgkin Lymphoma

Interventions

• DRUG

No Results Yet

NCT05641155 | COMPLETED | NA

18 participants

A Feasibility Study Evaluating the Performance of Focused Multipolar Stimulation and Sound Coding in Adults.

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2023-06-02

Completion:

2025-02-06

Conditions

• Hearing Impairment, Sensorineural

Interventions

• DEVICE

Results Available

NCT05632809 | RECRUITING | PHASE2

39 participants

REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE)

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2023-01-10

Completion:

2027-12-31

Conditions

• Lung Cancer

Interventions

• DRUG

No Results Yet

NCT05621499 | ACTIVE_NOT_RECRUITING | NA

60 participants

HAIC or Lenvatinib Combined With Sintilimab for High Recurrence Risk Resectable Solitary Hepatocellular Carcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2022-12-20

Completion:

2026-11-30

Conditions

• Hepatocellular Carcinoma

Interventions

• DRUG

No Results Yet

NCT05599347 | RECRUITING | PHASE2

180 participants

Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2023-04-24

Completion:

2026-09-10

Conditions

• Crohn's Disease Relapse
• Biological Substance; Adverse Effect

Interventions

• DRUG
• OTHER

No Results Yet

NCT05575440 | RECRUITING

24 participants

Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-29

Start Date:

2022-04-22

Completion:

2028-05-01

Conditions

• Differentiated Thyroid Gland Carcinoma
• Thyroid Gland Follicular Carcinoma
• Thyroid Gland Papillary Carcinoma

Interventions

• PROCEDURE
• RADIATION
• OTHER

No Results Yet

NCT05563870 | COMPLETED | NA

26 participants

Endoscopy and Radiology-guided Ablation for Inoperable Cholangiocarcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2022-08-01

Completion:

2026-07-20

Conditions

• Perihilar Cholangiocarcinoma

Interventions

• PROCEDURE

No Results Yet

NCT05536141 | RECRUITING | PHASE1

362 participants

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2022-10-26

Completion:

2029-03-31

Conditions

• Clear Cell Renal Cell Carcinoma
• Solid Tumors

Interventions

• DRUG

No Results Yet

NCT05487417 | COMPLETED | PHASE4

189 participants

Effects of Minocycline on Patients With Ischemic Stroke Undergoing Intravenous Thrombectomy

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2022-11-01

Completion:

2025-06-10

Conditions

• Ischemic Stroke, Acute

Interventions

• DRUG

No Results Yet

NCT05422846 | COMPLETED | NA

51 participants

Investigation of the Effects of Different Exercise on Wound Healing in Patients wıth Diabetic Foot Wounds

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2022-08-01

Completion:

2023-02-01

Conditions

• Diabetic Foot Ulcer
• Wound

Interventions

• OTHER

No Results Yet

NCT05417789 | ACTIVE_NOT_RECRUITING | PHASE3

128 participants

Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2024-10-09

Completion:

2025-12-23

Conditions

• TGCT

Interventions

• DRUG

No Results Yet

NCT05411523 | RECRUITING

20 participants

Assessing Effect of Spinal Cord Stimulation on Pain and Quality of Life With Chemotherapy-Induced Peripheral Neuropathy

Study Type:

OBSERVATIONAL

Last Updated:

2026-07-29

Start Date:

2022-04-14

Completion:

2028-04-15

Conditions

• Chemotherapy-Induced Peripheral Neuropathy
• Hematopoietic and Lymphoid System Neoplasm
• Malignant Solid Neoplasm

Interventions

• OTHER
• PROCEDURE

No Results Yet

NCT05395767 | RECRUITING | NA

40 participants

LIVing Donor Allograft for Anterior Cruciate Ligament Reconstruction Study

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2021-09-15

Completion:

2026-09-30

Conditions

• ACL

Interventions

• PROCEDURE

No Results Yet

NCT05380856 | RECRUITING | NA

60 participants

Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2023-09-26

Completion:

2027-03-01

Conditions

• Neurogenic Dysfunction of the Urinary Bladder
• Multiple Sclerosis
• Sacral Neuromodulation
• Bowel Dysfunction
• Sexual Dysfunction
• Quality of Life

Interventions

• DEVICE

No Results Yet

NCT05374109 | COMPLETED | NA

690 participants

SYV: A Mental Health Intervention to Improve HIV Outcomes in Tanzanian Youth

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2023-03-01

Completion:

2024-12-20

Conditions

• HIV-1-infection
• Mental Health Issue
• Adherence, Medication

Interventions

• BEHAVIORAL

Results Available

NCT05365659 | RECRUITING | PHASE1

140 participants

IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2023-09-05

Completion:

2027-09-30

Conditions

• B-cell Non-Hodgkin Lymphoma
• Diffuse Large B Cell Lymphoma
• Follicular Lymphoma
• Mantle Cell Lymphoma
• B-cell Lymphoma

Interventions

• DRUG

No Results Yet

NCT05357794 | RECRUITING | PHASE2

30 participants

Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2022-10-13

Completion:

2027-01-30

Conditions

• Mycosis Fungoides

Interventions

• DRUG

No Results Yet

NCT05356013 | COMPLETED | PHASE2

60 participants

Caplyta in Borderline Personality Disorder

Study Type:

INTERVENTIONAL

Last Updated:

2026-07-29

Start Date:

2023-05-10

Completion:

2025-12-31

Conditions

• Borderline Personality Disorder

Interventions

• DRUG

Results Available